ATLASATLAS fair value
CHF 117.26
Close to fair value · 1% premium
Range: CHF 97–CHF 141Fair valuePrice
Medacta (MOVE.SW)
Medacta stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · SIX Swiss Exchange · Switzerland
CHF 118.80▼ -1.00%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Medacta in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Medacta
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Medacta's fair value at about CHF 117.26 per share (reasonable range: CHF 96.75 to CHF 140.71). At CHF 118.80, the stock trades within 8% of that figure: close to fair value.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Medacta a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 114.43 and CHF 124.20; in 9 out of 10, between CHF 106.42 and CHF 133.55. Estimated annual volatility is 23%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 2.3B
- Market cap (USD)
- $2.8B
- P/E ratio
- 32.5
- Dividend yield
- 1.03%
- 52-week high
- CHF 177.20
- 52-week low
- CHF 107.40
- Revenue (12 months)
- €708M
- Gross margin
- 65.5%
- Operating margin
- 15.0%
- Net margin
- 10.9%
- Beta
- 1.01
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Medacta sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MOVE.SW has traded between CHF 107.40 and CHF 177.20. Today it is 33.0% below that high and 11% above its low.
On the business: net margin is 10.9%; it trades at 32.5 times earnings.
Its beta is 1.01: it moves roughly in line with the market.
About the company
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa.
Want to see everything about Medacta?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Medacta (MOVE.SW) fair value?
About CHF 117.26 per share according to ATLAS (reasonable range: CHF 96.75 to CHF 140.71). With the stock at CHF 118.80, it is close to that value.
What is the chance MOVE.SW goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, MOVE.SW ends the month between CHF 114.43 and CHF 124.20.
How big is Medacta and what is its P/E ratio?
Medacta's market capitalization is CHF 2.3B. Its price-to-earnings (P/E) ratio is 32.5: you pay CHF 32.5 for each CHF 1.00 of yearly earnings.
Does Medacta pay a dividend?
Yes. MOVE.SW's current dividend yield is 1.03% at today's price (CHF 118.80).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer